641 – 650 of 2811
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Letter by Schomburg and Melander Regarding Article, "Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension : A Possible Novel Therapeutic Target"
- Contribution to journal › Letter
-
Mark
Reply to : Confounding Factors in Predicting Acute Post-Surgical Pain
- Contribution to journal › Letter
-
Mark
Sertraline or placebo in chronic breathlessness? Lessons from placebo research
- Contribution to journal › Letter
-
Mark
Oligomerization status and post-translational modification of adiponectin : A possible association between adiponectin and risk of coronary artery disease
- Contribution to journal › Letter
-
Mark
Letter : different risks of venous thromboembolism in subsets of patients with inflammatory bowel diseases
- Contribution to journal › Letter
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
- Contribution to journal › Letter
-
Mark
Much ado about Biologicals : Highlights of the Master Class on Biologicals, Prague, 2018
- Contribution to journal › Letter
-
Mark
High versus low dose caffeine in preterm infants
- Contribution to journal › Letter
-
Mark
Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL) : A novel measure of quality of life for patients with systemic sclerosis
- Contribution to journal › Letter
-
Mark
Keloid formation after syndactyly release in a patient with macrodactyly – methotrexate treatment
- Contribution to journal › Letter
